Probing the characteristics and biofunctional effects of disease-affected cells and drug response via machine learning applications.
Deborah MudaliJaison JeevanandhamMichael Kobina DanquahPublished in: Critical reviews in biotechnology (2020)
Drug-induced transformations in disease characteristics at the cellular and molecular level offers the opportunity to predict and evaluate the efficacy of pharmaceutical ingredients whilst enabling the optimal design of new and improved drugs with enhanced pharmacokinetics and pharmacodynamics. Machine learning is a promising in-silico tool used to simulate cells with specific disease properties and to determine their response toward drug uptake. Differences in the properties of normal and infected cells, including biophysical, biochemical and physiological characteristics, plays a key role in developing fundamental cellular probing platforms for machine learning applications. Cellular features can be extracted periodically from both the drug treated, infected, and normal cells via image segmentations in order to probe dynamic differences in cell behavior. Cellular segmentation can be evaluated to reflect the levels of drug effect on a distinct cell or group of cells via probability scoring. This article provides an account for the use of machine learning methods to probe differences in the biophysical, biochemical and physiological characteristics of infected cells in response to pharmacokinetics uptake of drug ingredients for application in cancer, diabetes and neurodegenerative disease therapies.
Keyphrases
- induced apoptosis
- machine learning
- cell cycle arrest
- drug induced
- type diabetes
- deep learning
- endoplasmic reticulum stress
- cardiovascular disease
- cell death
- adipose tissue
- artificial intelligence
- oxidative stress
- single cell
- skeletal muscle
- single molecule
- cell proliferation
- big data
- young adults
- pi k akt
- mesenchymal stem cells